MoneyWorks4Me

Lupin reports 2-fold rise in Q3 net profit

31 Jan 2013 Evaluate

Lupin has reported results for third quarter ended December 31, 2012.

The company has posted over 2-fold rise in its net profit at Rs 448.30 crore for the quarter as compared to Rs 214.61 crore for the same quarter in the previous year.  Total income of the company has increased by 42.36% at Rs 2002.77 crore for quarter under review as compared to Rs 1406.85 crore for the quarter ended December 31, 2011.

On consolidated basis, the company has reported 42.61% rise in its net profit at Rs 335.23 crore for the quarter ended December 31, 2012 as compared to Rs 235.06  crore for the same quarter in the previous year. Total income of the company has increased by 38.71% at Rs 2527.57 crore for quarter under review as compared to Rs 1822.24 crore for the quarter ended December 31, 2011.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..